Table of Content

1 Report Overview
1.1 Psilocybin Assisted Therapy Definition
1.2 Market by Type
1.2.1 Global Psilocybin Assisted Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Natural
1.2.3 Synthetic
1.3 Market Segment by Application
1.3.1 Global Psilocybin Assisted Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Cluster Headaches
1.3.3 Anxiety Disorders
1.3.4 Psychiatric Disorders
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Psilocybin Assisted Therapy Sales
2.1 Global Psilocybin Assisted Therapy Revenue Estimates and Forecasts 2018-2034
2.2 Global Psilocybin Assisted Therapy Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Psilocybin Assisted Therapy Revenue by Region
2.3.1 Global Psilocybin Assisted Therapy Revenue by Region (2018-2024)
2.3.2 Global Psilocybin Assisted Therapy Revenue by Region (2024-2034)
2.4 Global Psilocybin Assisted Therapy Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Psilocybin Assisted Therapy Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Psilocybin Assisted Therapy Sales Quantity by Region
2.6.1 Global Psilocybin Assisted Therapy Sales Quantity by Region (2018-2024)
2.6.2 Global Psilocybin Assisted Therapy Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Psilocybin Assisted Therapy Sales Quantity by Manufacturers
3.1.1 Global Psilocybin Assisted Therapy Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Psilocybin Assisted Therapy Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Psilocybin Assisted Therapy Sales in 2022
3.2 Global Psilocybin Assisted Therapy Revenue by Manufacturers
3.2.1 Global Psilocybin Assisted Therapy Revenue by Manufacturers (2018-2024)
3.2.2 Global Psilocybin Assisted Therapy Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Psilocybin Assisted Therapy Revenue in 2022
3.3 Global Psilocybin Assisted Therapy Sales Price by Manufacturers
3.4 Global Key Players of Psilocybin Assisted Therapy, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Psilocybin Assisted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Psilocybin Assisted Therapy, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Psilocybin Assisted Therapy, Product Offered and Application
3.8 Global Key Manufacturers of Psilocybin Assisted Therapy, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Psilocybin Assisted Therapy Sales Quantity by Type
4.1.1 Global Psilocybin Assisted Therapy Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Psilocybin Assisted Therapy Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2034)
4.2 Global Psilocybin Assisted Therapy Revenue by Type
4.2.1 Global Psilocybin Assisted Therapy Historical Revenue by Type (2018-2024)
4.2.2 Global Psilocybin Assisted Therapy Forecasted Revenue by Type (2024-2034)
4.2.3 Global Psilocybin Assisted Therapy Revenue Market Share by Type (2018-2034)
4.3 Global Psilocybin Assisted Therapy Price by Type
4.3.1 Global Psilocybin Assisted Therapy Price by Type (2018-2024)
4.3.2 Global Psilocybin Assisted Therapy Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Psilocybin Assisted Therapy Sales Quantity by Application
5.1.1 Global Psilocybin Assisted Therapy Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Psilocybin Assisted Therapy Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2034)
5.2 Global Psilocybin Assisted Therapy Revenue by Application
5.2.1 Global Psilocybin Assisted Therapy Historical Revenue by Application (2018-2024)
5.2.2 Global Psilocybin Assisted Therapy Forecasted Revenue by Application (2024-2034)
5.2.3 Global Psilocybin Assisted Therapy Revenue Market Share by Application (2018-2034)
5.3 Global Psilocybin Assisted Therapy Price by Application
5.3.1 Global Psilocybin Assisted Therapy Price by Application (2018-2024)
5.3.2 Global Psilocybin Assisted Therapy Price Forecast by Application (2024-2034)
6 North America
6.1 North America Psilocybin Assisted Therapy Sales by Company
6.1.1 North America Psilocybin Assisted Therapy Revenue by Company (2018-2024)
6.1.2 North America Psilocybin Assisted Therapy Sales Quantity by Company (2018-2024)
6.2 North America Psilocybin Assisted Therapy Market Size by Type
6.2.1 North America Psilocybin Assisted Therapy Sales Quantity by Type (2018-2034)
6.2.2 North America Psilocybin Assisted Therapy Revenue by Type (2018-2034)
6.3 North America Psilocybin Assisted Therapy Market Size by Application
6.3.1 North America Psilocybin Assisted Therapy Sales Quantity by Application (2018-2034)
6.3.2 North America Psilocybin Assisted Therapy Revenue by Application (2018-2034)
6.4 North America Psilocybin Assisted Therapy Market Size by Country
6.4.1 North America Psilocybin Assisted Therapy Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Psilocybin Assisted Therapy Revenue by Country (2018-2034)
6.4.3 North America Psilocybin Assisted Therapy Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Psilocybin Assisted Therapy Sales by Company
7.1.1 Europe Psilocybin Assisted Therapy Sales Quantity by Company (2018-2024)
7.1.2 Europe Psilocybin Assisted Therapy Revenue by Company (2018-2024)
7.2 Europe Psilocybin Assisted Therapy Market Size by Type
7.2.1 Europe Psilocybin Assisted Therapy Sales Quantity by Type (2018-2034)
7.2.2 Europe Psilocybin Assisted Therapy Revenue by Type (2018-2034)
7.3 Europe Psilocybin Assisted Therapy Market Size by Application
7.3.1 Europe Psilocybin Assisted Therapy Sales Quantity by Application (2018-2034)
7.3.2 Europe Psilocybin Assisted Therapy Revenue by Application (2018-2034)
7.4 Europe Psilocybin Assisted Therapy Market Size by Country
7.4.1 Europe Psilocybin Assisted Therapy Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Psilocybin Assisted Therapy Revenue by Country (2018-2034)
7.4.3 Europe Psilocybin Assisted Therapy Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Psilocybin Assisted Therapy Sales by Company
8.1.1 China Psilocybin Assisted Therapy Sales Quantity by Company (2018-2024)
8.1.2 China Psilocybin Assisted Therapy Revenue by Company (2018-2024)
8.2 China Psilocybin Assisted Therapy Market Size by Type
8.2.1 China Psilocybin Assisted Therapy Sales Quantity by Type (2018-2034)
8.2.2 China Psilocybin Assisted Therapy Revenue by Type (2018-2034)
8.3 China Psilocybin Assisted Therapy Market Size by Application
8.3.1 China Psilocybin Assisted Therapy Sales Quantity by Application (2018-2034)
8.3.2 China Psilocybin Assisted Therapy Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Psilocybin Assisted Therapy Sales by Company
9.1.1 APAC Psilocybin Assisted Therapy Sales Quantity by Company (2018-2024)
9.1.2 APAC Psilocybin Assisted Therapy Revenue by Company (2018-2024)
9.2 APAC Psilocybin Assisted Therapy Market Size by Type
9.2.1 APAC Psilocybin Assisted Therapy Sales Quantity by Type (2018-2034)
9.2.2 APAC Psilocybin Assisted Therapy Revenue by Type (2018-2034)
9.3 APAC Psilocybin Assisted Therapy Market Size by Application
9.3.1 APAC Psilocybin Assisted Therapy Sales Quantity by Application (2018-2034)
9.3.2 APAC Psilocybin Assisted Therapy Revenue by Application (2018-2034)
9.4 APAC Psilocybin Assisted Therapy Market Size by Region
9.4.1 APAC Psilocybin Assisted Therapy Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Psilocybin Assisted Therapy Revenue by Region (2018-2034)
9.4.3 APAC Psilocybin Assisted Therapy Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales by Company
10.1.1 Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Psilocybin Assisted Therapy Market Size by Type
10.2.1 Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Psilocybin Assisted Therapy Market Size by Application
10.3.1 Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Psilocybin Assisted Therapy Market Size by Country
10.4.1 Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 MindMed
11.1.1 MindMed Company Information
11.1.2 MindMed Overview
11.1.3 MindMed Psilocybin Assisted Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 MindMed Psilocybin Assisted Therapy Products and Services
11.1.5 MindMed Psilocybin Assisted Therapy SWOT Analysis
11.1.6 MindMed Recent Developments
11.2 Compass Pathways
11.2.1 Compass Pathways Company Information
11.2.2 Compass Pathways Overview
11.2.3 Compass Pathways Psilocybin Assisted Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Compass Pathways Psilocybin Assisted Therapy Products and Services
11.2.5 Compass Pathways Psilocybin Assisted Therapy SWOT Analysis
11.2.6 Compass Pathways Recent Developments
11.3 ATAI Life Sciences
11.3.1 ATAI Life Sciences Company Information
11.3.2 ATAI Life Sciences Overview
11.3.3 ATAI Life Sciences Psilocybin Assisted Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 ATAI Life Sciences Psilocybin Assisted Therapy Products and Services
11.3.5 ATAI Life Sciences Psilocybin Assisted Therapy SWOT Analysis
11.3.6 ATAI Life Sciences Recent Developments
11.4 Field Trip
11.4.1 Field Trip Company Information
11.4.2 Field Trip Overview
11.4.3 Field Trip Psilocybin Assisted Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Field Trip Psilocybin Assisted Therapy Products and Services
11.4.5 Field Trip Psilocybin Assisted Therapy SWOT Analysis
11.4.6 Field Trip Recent Developments
11.5 DemeRx
11.5.1 DemeRx Company Information
11.5.2 DemeRx Overview
11.5.3 DemeRx Psilocybin Assisted Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 DemeRx Psilocybin Assisted Therapy Products and Services
11.5.5 DemeRx Psilocybin Assisted Therapy SWOT Analysis
11.5.6 DemeRx Recent Developments
11.6 Eleusis
11.6.1 Eleusis Company Information
11.6.2 Eleusis Overview
11.6.3 Eleusis Psilocybin Assisted Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Eleusis Psilocybin Assisted Therapy Products and Services
11.6.5 Eleusis Psilocybin Assisted Therapy SWOT Analysis
11.6.6 Eleusis Recent Developments
11.7 Hikma Pharmaceuticals PLC
11.7.1 Hikma Pharmaceuticals PLC Company Information
11.7.2 Hikma Pharmaceuticals PLC Overview
11.7.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Products and Services
11.7.5 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy SWOT Analysis
11.7.6 Hikma Pharmaceuticals PLC Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Psilocybin Assisted Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Pfizer Psilocybin Assisted Therapy Products and Services
11.8.5 Pfizer Psilocybin Assisted Therapy SWOT Analysis
11.8.6 Pfizer Recent Developments
11.9 Verrian
11.9.1 Verrian Company Information
11.9.2 Verrian Overview
11.9.3 Verrian Psilocybin Assisted Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Verrian Psilocybin Assisted Therapy Products and Services
11.9.5 Verrian Psilocybin Assisted Therapy SWOT Analysis
11.9.6 Verrian Recent Developments
11.10 Jazz Pharmaceuticals
11.10.1 Jazz Pharmaceuticals Company Information
11.10.2 Jazz Pharmaceuticals Overview
11.10.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Jazz Pharmaceuticals Psilocybin Assisted Therapy Products and Services
11.10.5 Jazz Pharmaceuticals Psilocybin Assisted Therapy SWOT Analysis
11.10.6 Jazz Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Psilocybin Assisted Therapy Value Chain Analysis
12.2 Psilocybin Assisted Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Psilocybin Assisted Therapy Production Mode & Process
12.4 Psilocybin Assisted Therapy Sales and Marketing
12.4.1 Psilocybin Assisted Therapy Sales Channels
12.4.2 Psilocybin Assisted Therapy Distributors
12.5 Psilocybin Assisted Therapy Customers
13 Market Dynamics
13.1 Psilocybin Assisted Therapy Industry Trends
13.2 Psilocybin Assisted Therapy Market Drivers
13.3 Psilocybin Assisted Therapy Market Challenges
13.4 Psilocybin Assisted Therapy Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Natural
Table 3. Major Manufacturers of Synthetic
Table 4. Global Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Psilocybin Assisted Therapy Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Psilocybin Assisted Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2018-2024)
Table 8. Global Psilocybin Assisted Therapy Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2024-2034)
Table 10. Global Psilocybin Assisted Therapy Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global Psilocybin Assisted Therapy Sales by Region (2018-2024) & (K Units)
Table 12. Global Psilocybin Assisted Therapy Sales Market Share by Region (2018-2024)
Table 13. Global Psilocybin Assisted Therapy Sales by Region (2024-2034) & (K Units)
Table 14. Global Psilocybin Assisted Therapy Sales Market Share by Region (2024-2034)
Table 15. Global Psilocybin Assisted Therapy Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global Psilocybin Assisted Therapy Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Psilocybin Assisted Therapy Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Psilocybin Assisted Therapy Revenue Share by Manufacturers (2018-2024)
Table 19. Global Psilocybin Assisted Therapy Price by Manufacturers 2018-2024 (USD/Unit)
Table 20. Global Key Players of Psilocybin Assisted Therapy, Industry Ranking, 2021 VS 2022
Table 21. Global Psilocybin Assisted Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Psilocybin Assisted Therapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psilocybin Assisted Therapy as of 2022)
Table 23. Global Key Manufacturers of Psilocybin Assisted Therapy, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Psilocybin Assisted Therapy, Product Offered and Application
Table 25. Global Key Manufacturers of Psilocybin Assisted Therapy, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Psilocybin Assisted Therapy Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global Psilocybin Assisted Therapy Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Psilocybin Assisted Therapy Sales Quantity Share by Type (2018-2024)
Table 30. Global Psilocybin Assisted Therapy Sales Quantity Share by Type (2024-2034)
Table 31. Global Psilocybin Assisted Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Psilocybin Assisted Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Psilocybin Assisted Therapy Revenue Share by Type (2018-2024)
Table 34. Global Psilocybin Assisted Therapy Revenue Share by Type (2024-2034)
Table 35. Psilocybin Assisted Therapy Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Psilocybin Assisted Therapy Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Psilocybin Assisted Therapy Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global Psilocybin Assisted Therapy Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Psilocybin Assisted Therapy Sales Quantity Share by Application (2018-2024)
Table 40. Global Psilocybin Assisted Therapy Sales Quantity Share by Application (2024-2034)
Table 41. Global Psilocybin Assisted Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Psilocybin Assisted Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Psilocybin Assisted Therapy Revenue Share by Application (2018-2024)
Table 44. Global Psilocybin Assisted Therapy Revenue Share by Application (2024-2034)
Table 45. Psilocybin Assisted Therapy Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Psilocybin Assisted Therapy Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Psilocybin Assisted Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Psilocybin Assisted Therapy Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America Psilocybin Assisted Therapy Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America Psilocybin Assisted Therapy Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Psilocybin Assisted Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Psilocybin Assisted Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Psilocybin Assisted Therapy Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America Psilocybin Assisted Therapy Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Psilocybin Assisted Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Psilocybin Assisted Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Psilocybin Assisted Therapy Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Psilocybin Assisted Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Psilocybin Assisted Therapy Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Psilocybin Assisted Therapy Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America Psilocybin Assisted Therapy Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Psilocybin Assisted Therapy Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe Psilocybin Assisted Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Psilocybin Assisted Therapy Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe Psilocybin Assisted Therapy Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Psilocybin Assisted Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Psilocybin Assisted Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Psilocybin Assisted Therapy Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe Psilocybin Assisted Therapy Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Psilocybin Assisted Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Psilocybin Assisted Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Psilocybin Assisted Therapy Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Psilocybin Assisted Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Psilocybin Assisted Therapy Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Psilocybin Assisted Therapy Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe Psilocybin Assisted Therapy Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Psilocybin Assisted Therapy Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China Psilocybin Assisted Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Psilocybin Assisted Therapy Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China Psilocybin Assisted Therapy Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Psilocybin Assisted Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Psilocybin Assisted Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Psilocybin Assisted Therapy Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China Psilocybin Assisted Therapy Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Psilocybin Assisted Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Psilocybin Assisted Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Psilocybin Assisted Therapy Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC Psilocybin Assisted Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Psilocybin Assisted Therapy Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC Psilocybin Assisted Therapy Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Psilocybin Assisted Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Psilocybin Assisted Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Psilocybin Assisted Therapy Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC Psilocybin Assisted Therapy Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Psilocybin Assisted Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Psilocybin Assisted Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Psilocybin Assisted Therapy Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Psilocybin Assisted Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Psilocybin Assisted Therapy Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Psilocybin Assisted Therapy Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC Psilocybin Assisted Therapy Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity by Country (2024-2034) & (K Units)
Table 117. MindMed Company Information
Table 118. MindMed Description and Overview
Table 119. MindMed Psilocybin Assisted Therapy Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 120. MindMed Psilocybin Assisted Therapy Product and Services
Table 121. MindMed Psilocybin Assisted Therapy SWOT Analysis
Table 122. MindMed Recent Developments
Table 123. Compass Pathways Company Information
Table 124. Compass Pathways Description and Overview
Table 125. Compass Pathways Psilocybin Assisted Therapy Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 126. Compass Pathways Psilocybin Assisted Therapy Product and Services
Table 127. Compass Pathways Psilocybin Assisted Therapy SWOT Analysis
Table 128. Compass Pathways Recent Developments
Table 129. ATAI Life Sciences Company Information
Table 130. ATAI Life Sciences Description and Overview
Table 131. ATAI Life Sciences Psilocybin Assisted Therapy Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 132. ATAI Life Sciences Psilocybin Assisted Therapy Product and Services
Table 133. ATAI Life Sciences Psilocybin Assisted Therapy SWOT Analysis
Table 134. ATAI Life Sciences Recent Developments
Table 135. Field Trip Company Information
Table 136. Field Trip Description and Overview
Table 137. Field Trip Psilocybin Assisted Therapy Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 138. Field Trip Psilocybin Assisted Therapy Product and Services
Table 139. Field Trip Psilocybin Assisted Therapy SWOT Analysis
Table 140. Field Trip Recent Developments
Table 141. DemeRx Company Information
Table 142. DemeRx Description and Overview
Table 143. DemeRx Psilocybin Assisted Therapy Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 144. DemeRx Psilocybin Assisted Therapy Product and Services
Table 145. DemeRx Psilocybin Assisted Therapy SWOT Analysis
Table 146. DemeRx Recent Developments
Table 147. Eleusis Company Information
Table 148. Eleusis Description and Overview
Table 149. Eleusis Psilocybin Assisted Therapy Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 150. Eleusis Psilocybin Assisted Therapy Product and Services
Table 151. Eleusis Psilocybin Assisted Therapy SWOT Analysis
Table 152. Eleusis Recent Developments
Table 153. Hikma Pharmaceuticals PLC Company Information
Table 154. Hikma Pharmaceuticals PLC Description and Overview
Table 155. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 156. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product and Services
Table 157. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy SWOT Analysis
Table 158. Hikma Pharmaceuticals PLC Recent Developments
Table 159. Pfizer Company Information
Table 160. Pfizer Description and Overview
Table 161. Pfizer Psilocybin Assisted Therapy Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 162. Pfizer Psilocybin Assisted Therapy Product and Services
Table 163. Pfizer Psilocybin Assisted Therapy SWOT Analysis
Table 164. Pfizer Recent Developments
Table 165. Verrian Company Information
Table 166. Verrian Description and Overview
Table 167. Verrian Psilocybin Assisted Therapy Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 168. Verrian Psilocybin Assisted Therapy Product and Services
Table 169. Verrian Psilocybin Assisted Therapy SWOT Analysis
Table 170. Verrian Recent Developments
Table 171. Jazz Pharmaceuticals Company Information
Table 172. Jazz Pharmaceuticals Description and Overview
Table 173. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 174. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product and Services
Table 175. Jazz Pharmaceuticals Psilocybin Assisted Therapy SWOT Analysis
Table 176. Jazz Pharmaceuticals Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Psilocybin Assisted Therapy Distributors List
Table 180. Psilocybin Assisted Therapy Customers List
Table 181. Psilocybin Assisted Therapy Market Trends
Table 182. Psilocybin Assisted Therapy Market Drivers
Table 183. Psilocybin Assisted Therapy Market Challenges
Table 184. Psilocybin Assisted Therapy Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Psilocybin Assisted Therapy Product Picture
Figure 2. Global Psilocybin Assisted Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Psilocybin Assisted Therapy Market Share by Type in 2022 & 2034
Figure 4. Natural Product Picture
Figure 5. Synthetic Product Picture
Figure 6. Global Psilocybin Assisted Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Psilocybin Assisted Therapy Market Share by Application in 2022 & 2034
Figure 8. Cluster Headaches
Figure 9. Anxiety Disorders
Figure 10. Psychiatric Disorders
Figure 11. Psilocybin Assisted Therapy Report Years Considered
Figure 12. Global Psilocybin Assisted Therapy Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Psilocybin Assisted Therapy Revenue 2018-2034 (US$ Million)
Figure 14. Global Psilocybin Assisted Therapy Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Psilocybin Assisted Therapy Sales Quantity 2018-2034 (K Units)
Figure 16. Global Psilocybin Assisted Therapy Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Psilocybin Assisted Therapy Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Psilocybin Assisted Therapy Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America Psilocybin Assisted Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Psilocybin Assisted Therapy Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe Psilocybin Assisted Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Psilocybin Assisted Therapy Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China Psilocybin Assisted Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Psilocybin Assisted Therapy Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC Psilocybin Assisted Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Psilocybin Assisted Therapy Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Psilocybin Assisted Therapy Revenue in 2022
Figure 30. Psilocybin Assisted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2018-2034)
Figure 33. Global Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2018-2034)
Figure 35. North America Psilocybin Assisted Therapy Revenue Market Share by Company in 2022
Figure 36. North America Psilocybin Assisted Therapy Sales Quantity Market Share by Company in 2022
Figure 37. North America Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Psilocybin Assisted Therapy Revenue Market Share by Type (2018-2034)
Figure 39. North America Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Psilocybin Assisted Therapy Revenue Market Share by Application (2018-2034)
Figure 41. North America Psilocybin Assisted Therapy Revenue Share by Country (2018-2034)
Figure 42. North America Psilocybin Assisted Therapy Sales Quantity Share by Country (2018-2034)
Figure 43. United States Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Psilocybin Assisted Therapy Sales Quantity Market Share by Company in 2022
Figure 46. Europe Psilocybin Assisted Therapy Revenue Market Share by Company in 2022
Figure 47. Europe Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Psilocybin Assisted Therapy Revenue Market Share by Type (2018-2034)
Figure 49. Europe Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Psilocybin Assisted Therapy Revenue Market Share by Application (2018-2034)
Figure 51. Europe Psilocybin Assisted Therapy Revenue Share by Country (2018-2034)
Figure 52. Europe Psilocybin Assisted Therapy Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 54. France Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 58. China Psilocybin Assisted Therapy Sales Quantity Market Share by Company in 2022
Figure 59. China Psilocybin Assisted Therapy Revenue Market Share by Company in 2022
Figure 60. China Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Psilocybin Assisted Therapy Revenue Market Share by Type (2018-2034)
Figure 62. China Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Psilocybin Assisted Therapy Revenue Market Share by Application (2018-2034)
Figure 64. APAC Psilocybin Assisted Therapy Sales Quantity Market Share by Company in 2022
Figure 65. APAC Psilocybin Assisted Therapy Revenue Market Share by Company in 2022
Figure 66. APAC Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Psilocybin Assisted Therapy Revenue Market Share by Type (2018-2034)
Figure 68. APAC Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Psilocybin Assisted Therapy Revenue Market Share by Application (2018-2034)
Figure 70. APAC Psilocybin Assisted Therapy Revenue Share by Region (2018-2034)
Figure 71. APAC Psilocybin Assisted Therapy Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 76. India Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue Share by Country (2018-2034)
Figure 85. Brazil Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Psilocybin Assisted Therapy Revenue (2018-2034) & (US$ Million)
Figure 90. Psilocybin Assisted Therapy Value Chain
Figure 91. Psilocybin Assisted Therapy Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed